.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Federal Trade Commission
Colorcon
Cantor Fitzgerald
QuintilesIMS
US Army
Teva
Johnson and Johnson
Chubb
Harvard Business School

Generated: December 15, 2017

DrugPatentWatch Database Preview

ZECUITY Drug Profile

« Back to Dashboard

When do Zecuity patents expire, and what generic alternatives are available?

Zecuity is a drug marketed by Teva Branded Pharm and is included in one NDA. There are ten patents protecting this drug.

This drug has one hundred and four patent family members in fifteen countries.

The generic ingredient in ZECUITY is sumatriptan succinate. There are twenty-three drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Teva Branded PharmZECUITYsumatriptan succinateSYSTEM;IONTOPHORESIS202278-001Jan 17, 2013DISCNYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Teva Branded PharmZECUITYsumatriptan succinateSYSTEM;IONTOPHORESIS202278-001Jan 17, 2013DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva Branded PharmZECUITYsumatriptan succinateSYSTEM;IONTOPHORESIS202278-001Jan 17, 2013DISCNYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Teva Branded PharmZECUITYsumatriptan succinateSYSTEM;IONTOPHORESIS202278-001Jan 17, 2013DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva Branded PharmZECUITYsumatriptan succinateSYSTEM;IONTOPHORESIS202278-001Jan 17, 2013DISCNYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Teva Branded PharmZECUITYsumatriptan succinateSYSTEM;IONTOPHORESIS202278-001Jan 17, 2013DISCNYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Teva Branded PharmZECUITYsumatriptan succinateSYSTEM;IONTOPHORESIS202278-001Jan 17, 2013DISCNYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Teva Branded PharmZECUITYsumatriptan succinateSYSTEM;IONTOPHORESIS202278-001Jan 17, 2013DISCNYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Teva Branded PharmZECUITYsumatriptan succinateSYSTEM;IONTOPHORESIS202278-001Jan 17, 2013DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva Branded PharmZECUITYsumatriptan succinateSYSTEM;IONTOPHORESIS202278-001Jan 17, 2013DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ZECUITY

Country Document Number Estimated Expiration
New Zealand590356► Subscribe
Japan5662312► Subscribe
Hong Kong1205026► Subscribe
South Korea100735939► Subscribe
Israel238603► Subscribe
World Intellectual Property Organization (WIPO)2004075980► Subscribe
China101472644► Subscribe
European Patent Office2643048► Subscribe
Japan2006513768► Subscribe
Hong Kong1162992► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Cipla
Johnson and Johnson
Citi
Farmers Insurance
Covington
AstraZeneca
Moodys
Baxter
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot